Risk Evaluation for Aseptic Preparation

A. M. Beaney Regional Quality Assurance Specialist
North-East England, UK

Risks to patients are greater when injectable medicines are prepared in clinical areas such as wards and theatres than when they are prepared in pharmacy. Ideally all injectable medicines should be prepared in pharmacy where standards are defined (Beaney 2006) [1] and provided to clinical areas in ready-to-use form. Unfortunately, however, aseptic capacity within pharmacy is limited and the pharmaceutical industry has been slow to develop ready-to-use formulations. Consequently nurses continue to prepare the majority of injectable medicines in most cases (Beaney & Goode 2003)Beaney AM, Goode J (2003) [2].

To make best use of the limited capacity within pharmacy aseptic units, risk evaluation is a way of prioritising those products with higher risk for preparation by pharmacy. A risk assessment tool was developed (Beaney et al 2005) [3] to help the targeted transfer of products to pharmacy. This tool became the basis of a patient safety alert in the UK (NPSA 2007) [4] requiring risk assessment of practices and individual injectable products prepared in all clinical areas. The risk assessment allows ranking of product with the aim of reducing risks by providing them in ready-to-use form or by giving guidance such as dose calculation tools.

Nurses preparing products of lower risk that continue to be prepared in clinical areas should be supported by pharmacy involvement in their training and given advice on non-touch techniques (Beaney et al 2005 [3], Beaney & Black 2012 [5]).

The Council of Europe Resolution (2001) [6] on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients includes a section on reconstitution. This states that a risk assessment should be undertaken to identify higher risk products for pharmacy preparation. Lower risk products can be prepared in clinical areas with suitable training. Further guidance is currently being produced on this topic by an EDQM expert working party.

[1Beaney AM (2006) Quality Assurance of Aseptic Preparation Services. London : Pharmaceutical Press

[2A risk assessment of the ward-based preparation of parenteral medicines. Hospital Pharmacist ; 10 : 7, 306-308

[3Beaney AM et al (2005) Development of a risk assessment tool to improve the safety of patients receiving intravenous medication. Hospital Pharmacist ; 12 : 150-154

[4National Patient Safety Agency (2007) Patient Safety Alert 20. Promoting Safer Use of Injectable Medicines. London : NPSA

[5Beaney AM, Black A (2012). Preparing Injectable Medicines Safely. Nursing Times, 108, No 3, 20-23

[6Council of Europe Resolution CM/ResAP (2001) 1

Forum de discussion

Le GERPAC met à disposition des adhérents à jour de leur cotisation un forum dédié spécifiquement aux discussions sur la PHARMACOTECHNIE

Aller au forum

GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contacts Mentions légales - Gestion des données personnelles